TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
MGNX

MacroGenics Inc

Healthcare · Biotechnology

4.10$ +1.2% vs. previous close Closing price · As of: Sep 17, 2026

Filings

Filings

Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of MacroGenics Inc (MGNX) with date, type and a link to the original document.

Filings MGNX
Date Type Filing Original
08/19/2026 Insider sale notice Form 144 filed with the SEC View document ↗
08/17/2026 Insider sale notice Form 144 filed with the SEC View document ↗
08/13/2026 Current report (8-K) MACROGENICS INC (MGNX): Results of Operations and Financial Condition; Financial Statements and Exhibits View report ↗
08/03/2026 Insider sale notice Form 144 filed with the SEC View document ↗
07/29/2026 Ownership disclosure Form SC 13G filed with the SEC View document ↗
07/23/2026 Current report (8-K) MACROGENICS INC (MGNX): Other Events View report ↗
07/13/2026 Insider sale notice Form 144 filed with the SEC View document ↗
07/08/2026 Current report (8-K) MACROGENICS INC (MGNX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers View report ↗
07/07/2026 Current report (8-K) MACROGENICS INC (MGNX): Completion of Acquisition or Disposition of Assets; Regulation FD Disclosure; Financial Statements and Exhibits View report ↗

Showing the 100 most recent filings of the selected type.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?